Identification of nuclear export inhibitor-based combination therapies in preclinical models of triple-negative breast cancer
出版年份 2021 全文链接
标题
Identification of nuclear export inhibitor-based combination therapies in preclinical models of triple-negative breast cancer
作者
关键词
Breast cancer, TNBC, KPT-330, GSK2126458, XPO1
出版物
Translational Oncology
Volume 14, Issue 12, Pages 101235
出版商
Elsevier BV
发表日期
2021-10-09
DOI
10.1016/j.tranon.2021.101235
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Identification of synergistic drug combinations using breast cancer patient-derived xenografts
- (2020) Tia H. Turner et al. Scientific Reports
- G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer
- (2020) Masanori Oshi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer
- (2020) Maria Gagliardi et al. Scientific Reports
- Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancer
- (2020) Reid T. Powell et al. Scientific Reports
- A metastasis map of human cancer cell lines
- (2020) Xin Jin et al. NATURE
- A Phase II Trial of Selinexor (KPT‐330) for Metastatic Triple‐Negative Breast Cancer
- (2019) Michael Shafique et al. ONCOLOGIST
- Exportin 1 inhibition induces nerve growth factor receptor expression to inhibit the NF-kB pathway in preclinical models of pediatric high-grade glioma
- (2019) John A. DeSisto et al. MOLECULAR CANCER THERAPEUTICS
- High-Speed Live-Cell Interferometry: A New Method for Quantifying Tumor Drug Resistance and Heterogeneity
- (2018) Dian Huang et al. ANALYTICAL CHEMISTRY
- Characterizing the efficacy of cancer therapeutics in patient-derived xenograft models of metastatic breast cancer
- (2018) Tia H. Turner et al. BREAST CANCER RESEARCH AND TREATMENT
- A subcellular map of the human proteome
- (2017) Peter J. Thul et al. SCIENCE
- A pathology atlas of the human cancer transcriptome
- (2017) Mathias Uhlen et al. SCIENCE
- Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
- (2017) Kuan-lin Huang et al. Nature Communications
- MultiQC: summarize analysis results for multiple tools and samples in a single report
- (2016) Philip Ewels et al. BIOINFORMATICS
- Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone
- (2016) Irfana Muqbil et al. CANCER LETTERS
- Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer
- (2016) Vikram B. Wali et al. CANCER RESEARCH
- A phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors
- (2016) J. E. Grilley-Olson et al. INVESTIGATIONAL NEW DRUGS
- Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids
- (2016) Kathrin Halfter et al. Journal of Translational Medicine
- Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death
- (2016) Trinayan Kashyap et al. Oncotarget
- An overview of triple-negative breast cancer
- (2015) Pankaj Kumar et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor Malignancies
- (2015) P. Munster et al. CLINICAL CANCER RESEARCH
- Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10-Dependent Apoptosis by Carfilzomib and Selinexor
- (2015) S. Rosebeck et al. MOLECULAR CANCER THERAPEUTICS
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer
- (2013) Miguel Martín et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer
- (2013) A. Prat et al. ONCOLOGIST
- Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
- (2013) Shunqiang Li et al. Cell Reports
- Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
- (2011) J. Chuck Harrell et al. BREAST CANCER RESEARCH AND TREATMENT
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
- (2011) Yoko S DeRose et al. NATURE MEDICINE
- Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients
- (2010) Hiroko Masuda et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Genes that mediate breast cancer metastasis to the brain
- (2009) Paula D. Bos et al. NATURE
- Treatment outcomes and clinicopathologic characteristics of triple-negative breast cancer patients who received platinum-containing chemotherapy
- (2008) Ji Eun Uhm et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More